Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

CNS 2Other solid neoplasm 1

Conditions

Oligodendroglioma 1Neurofibromatosis 1 1Hematopoietic and Lymphatic System Neoplasm 1Glioma 1Glioblastoma 1Astrocytoma 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1237Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Outcome Assessment, Health Care × Clear all
NCT06625047 2026-04-29

Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

Mayo Clinic

Phase 4 Completed
30 enrolled
CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

NCT06582030 2024-09-03

Stop Addiction Stigma

Ohio State University Comprehensive Cancer Center

Phase NA Completed
93 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT05186870 2023-03-03

Reliability of Functional Outcome Measures in Neurofibromatosis 1: Test- Retest

Guy's and St Thomas' NHS Foundation Trust

Unknown
20 enrolled
CNS

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡